Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: A multiple-centered, retrospective study
- PMID: 33592878
- PMCID: PMC7870254
- DOI: 10.1097/MD.0000000000024332
Clinical features and risk factors for severe-critically ill COVID-19 adult patients in Jiangsu, China: A multiple-centered, retrospective study
Abstract
Coronavirus disease 2019 (COVID-19) becomes a global pandemic in 2020. Early identification of severe ill patients is a top priority for clinicians. We aimed to describe clinical features and risk factors of severe-critically ill patients with COVID-19 in Jiangsu Province.This multi-centered retrospective study collected the information of 631 laboratory-confirmed COVID-19 patients hospitalized at 28 authorized hospitals in Jiangsu province from January 23, 2019 to March 13, 2020.A total of 583 adult patients with laboratory-confirmed COVID-19 were enrolled for final analysis, including 84 severe-critically ill patients and 499 mild-moderate patients. Median age of the severe-critically ill patients was 57.0 years old (interquartile range, 49.0-65.8), and 50 (59.5%) were males. Multisystemic laboratory abnormalities were observed on admission for severe-critically ill patients. These patients showed more noticeable radiologic abnormalities and more coexisting health issues as compared to the mild-moderate patients. Most of the severe-critically ill COVID-19 patients became deteriorated in 2 weeks after diagnosis. Age, D-dimer, and lymphocytes were independently associated with the progression of severe-critically illness.Older age, higher D-dimer levels and less lymphocyte counts on admission are potential risk factors for COVID-19 patients to develop into severe and critically illness.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures




Similar articles
-
Clinical characteristics and risk factors of patients with severe COVID-19 in Jiangsu province, China: a retrospective multicentre cohort study.BMC Infect Dis. 2020 Aug 6;20(1):584. doi: 10.1186/s12879-020-05314-x. BMC Infect Dis. 2020. PMID: 32762665 Free PMC article.
-
Clinical characteristics and outcomes of 48 patients hospitalized for COVID-19 infection in Wuxi: A retrospective cohort study.Medicine (Baltimore). 2021 Feb 5;100(5):e23991. doi: 10.1097/MD.0000000000023991. Medicine (Baltimore). 2021. PMID: 33592854 Free PMC article.
-
Clinical characteristics of 2,459 severe or critically ill COVID-19 patients: A meta-analysis.Medicine (Baltimore). 2021 Feb 5;100(5):e23781. doi: 10.1097/MD.0000000000023781. Medicine (Baltimore). 2021. PMID: 33592834 Free PMC article.
-
Hemostatic System (Fibrinogen Level, D-Dimer, and FDP) in Severe and Non-Severe Patients With COVID-19: A Systematic Review and Meta-Analysis.Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010973. doi: 10.1177/10760296211010973. Clin Appl Thromb Hemost. 2021. PMID: 34933579 Free PMC article.
-
Prognostic value of cardiac biomarkers in COVID-19 infection.Sci Rep. 2021 Mar 2;11(1):4930. doi: 10.1038/s41598-021-84643-6. Sci Rep. 2021. PMID: 33654230 Free PMC article. Review.
Cited by
-
Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients.Front Cardiovasc Med. 2022 Mar 11;9:794092. doi: 10.3389/fcvm.2022.794092. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35360017 Free PMC article.
-
Association between viral hepatitis and increased risk of severe coronavirus disease 2019 (COVID-19) outcome: a systematic review and meta-analysis.Gastroenterol Hepatol Bed Bench. 2022 Winter;15(1):9-14. Gastroenterol Hepatol Bed Bench. 2022. PMID: 35611257 Free PMC article. Review.
-
Jieji Xuanfei Chuyi granules in the treatment of COVID-19: A randomized, open-label, parallel-controlled clinical trial.Medicine (Baltimore). 2025 Mar 28;104(13):e41740. doi: 10.1097/MD.0000000000041740. Medicine (Baltimore). 2025. PMID: 40153774 Free PMC article. Clinical Trial.
-
COVID-19 susceptibility variants associate with blood clots, thrombophlebitis and circulatory diseases.PLoS One. 2021 Sep 3;16(9):e0256988. doi: 10.1371/journal.pone.0256988. eCollection 2021. PLoS One. 2021. PMID: 34478452 Free PMC article.
-
Anemia is associated with severe coronavirus disease 2019 (COVID-19) infection.Transfus Apher Sci. 2020 Dec;59(6):102926. doi: 10.1016/j.transci.2020.102926. Epub 2020 Aug 28. Transfus Apher Sci. 2020. PMID: 32893135 Free PMC article. No abstract available.
References
-
- WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. 2020. (Accessed 25 January 2020, https://www.who.int/docs/default-source/coronaviruse/clinical-management...)
-
- WHO. Coronavirus disease (COVID-19) Situation Report – 165. 2020. (Accessed 3 July 2020, https://www.who.int/docs/default-source/coronaviruse/situation-reports/2....
-
- WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020. 2020. (Accessed March 11 2020 at https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re...).
-
- Li J, Long X, Luo H, et al. Clinical Characteristics of Deceased Patients Infected with SARS-CoV-2 in Wuhan, China (2/24/2020). Available at SSRN: https://ssrn.com/abstract=3546043 or http://dx.doi.org/10.2139/ssrn.3546043. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical